文献速递神经头颈MR

肿瘤患者磁共振成像显示的脑膜强化:肿瘤性脑膜炎还是治疗相关强化?

Meningeal enhancement depicted by magnetic resonance imaging in tumor patients: neoplastic meningitis or therapy-related enhancement?
PubMed 文献 · Neuroradiology · 2019-04-18

回顾性评估2572次脑MRI,在黑色素瘤、乳腺癌、肺癌或淋巴瘤化疗患者中,病理性能见脑膜强化而脑脊液细胞学阴性的假阳性率低于1%,且无特定影像模式;11例(14.1%)重复细胞学阴性者中7例接受多模式免疫治疗,作者假设免疫治疗可能与「假性脑膜炎」相关,建议对疑似肿瘤性脑膜炎者分析脑脊液,尤其免疫治疗患者。

要点

  • 实体瘤化疗患者中脑膜强化假阳性率低于1%,且无特定影像模式可鉴别。
  • 11例重复脑脊液细胞学阴性者中7例接受多模式免疫治疗,提示可能关联。
  • 疑似肿瘤性脑膜炎时应行脑脊液分析确认诊断,尤其免疫治疗患者。

核心结论

  • 实体瘤化疗患者中脑膜强化假阳性率低(<1%),与特定影像模式无关;作者假设免疫治疗与「假性脑膜炎」可能存在关联,建议所有疑似肿瘤性脑膜炎病例行脑脊液分析确认诊断,尤其免疫治疗患者。

研究设计与样本

  • 回顾性评估2572次脑MRI,由两名阅片者判断有无提示肿瘤性脑膜炎的病理性脑膜强化,参考标准为脑脊液细胞学结果和随访MRI,最终纳入78例患者(51例女性,中位年龄57岁)。

关键影像表现/征象

  • 病理性强化在随访中减退且细胞学非恶性者,进一步描述为硬脑膜或软脑膜、局限或弥漫、幕上或幕下分布。
  • 细胞学无异常者的强化分布以幕上为主,与肿瘤性脑膜炎患者相比。
  • 1例颗粒性细胞增多被归因于既往放疗。

诊断标准与关键数值

  • 假阳性脑膜强化的总体患病率低于1%。
  • 最终队列78例中11例(14.1%)重复脑脊液细胞学为非恶性。

临床应用与阅片要点

  • 疑似肿瘤性脑膜炎时应分析脑脊液以确认诊断,尤其免疫治疗患者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the prevalence of false-positive meningeal contrast enhancement in patients with solid tumors who were undergoing chemotherapy.

METHODS: A total of 2572 magnetic resonance imaging (MRI) examinations of the brain were retrospectively evaluated by two readers for the presence of pathological meningeal contrast enhancement conspicuous for neoplastic meningitis. These patients either had malignant melanoma, breast or lung cancer, or lymphoma. The reference standards were cerebrospinal fluid cytology results and follow-up MRI. In cases with pathological contrast enhancement that decreased upon follow-up and non-malignant cytology, the enhancement pattern was further described as pial or dural, local or diffuse, or supra- or infra-tentorial. Moreover, the underlying therapy regimes were assessed.

RESULTS: The final study cohort included 78 patients (51 females, median age 57 years), of which 11 patients (14.1%) had a repeated non-malignant cytology ('pseudomeningeosis'). In one case, this finding, a granular pleocytosis, was attributed to previous radiotherapy. Of the remaining patients, seven were receiving multimodal, immunotherapy-based therapy regimens. Patients with unsuspicious cytology had a predominantly supratentorial distribution pattern in comparison to patients with neoplastic meningitis.

CONCLUSIONS: The overall prevalence of the presence of false-positive meningeal contrast enhancement is low (< 1%) and not associated with specific imaging patterns. We hypothesize that there is a possible relationship between immunotherapy and 'pseudomeningeosis'. Therefore, in all cases with suspected neoplastic meningitis, the cerebrospinal fluid should be analyzed to confirm the diagnosis, especially in patients undergoing immunotherapy.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Bier G, Klumpp B, Roder C, et al. Meningeal enhancement depicted by magnetic resonance imaging in tumor patients: neoplastic meningitis or therapy-related enhancement? Neuroradiology. 2019. PMID: 31001647. doi:10.1007/s00234-019-02215-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。